Skip to content
Screener

Septerna, Inc. SEPN Accrued Expenses

Accrued Expenses at other companies

Amgen logo
AmgenAMGN
$17.19B+14.4%
Tectonic Therapeutics logo
Tectonic TherapeuticsTECX
$8.97M+82.9%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$23.16M+233%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$13.45M+7.4%
Schrodinger logo
SchrodingerSDGR
$10.67M+3.9%
CYP
Cypherpunk TechnologiesCYPH
$1.97M-71.9%

Other financials

Income statement

See full
Revenue$26.7M+22,376%
Operating income-$16.8M+41.9%
Net income-$13.0M+47.5%
EPS (diluted)-$0.29+48.2%

Balance sheet

See full
Cash & equivalents$84.7M-55.3%
Total debt$22.5M-8.2%
Total equity$386.7M+2.4%
Total assets$566.7M+36.5%

Cash flow

See full
Operating cash flow-$22.2M-9.3%
CapEx$832.0K+118%
Free cash flow-$22.2M-9.0%

Valuation

See full
Market cap$1.75B+242%
Enterprise value$1.69B+386%
P/S17.7×-687×

Profitability

See full
Operating margin-44%-22.0pp
Net margin-24.5%-12.2pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-6.3%
Debt / equity0.1×0.0×
Current ratio-17.1×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The source filing: Septerna, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342353
Line itemJune 30, 2026December 31, 2025
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable$3,969$10,283
Accrued expenses and other current liabilities12,58412,167
Deferred revenue, current60,35462,269
Operating lease liabilities, current2,4092,212
Total current liabilities79,31686,931
Deferred revenue, non-current80,043105,917

Item 1. Condensed Financial Statements.

FAQ

What is Septerna, Inc.'s accrued expenses?
Septerna, Inc. (SEPN) reported accrued expenses of $12.58M in Q2 2026.
How has Septerna, Inc.'s accrued expenses changed year-over-year?
Septerna, Inc.'s accrued expenses increased by 91.9% year-over-year, from $6.56M to $12.58M.
What is the long-term trend for Septerna, Inc.'s accrued expenses?
Over 2 years (2023 to 2025), Septerna, Inc.'s accrued expenses has grown at a 68.7% compound annual growth rate (CAGR), from $4.28M to $12.17M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Septerna, Inc.'s accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude